Equivalent Dose Conversion: Vyvanse to Ritalin LA 30mg
A reasonable starting equivalent dose of Vyvanse (lisdexamfetamine) for a patient taking Ritalin LA 30mg would be approximately 50-70mg, though no precise conversion ratio exists in the literature.
Rationale for Dose Equivalency
The evidence does not provide a direct, validated conversion formula between methylphenidate and lisdexamfetamine. However, I can construct a reasonable approach based on the available pharmacological data:
Key Pharmacological Considerations
Dose-response data from network meta-analysis 1 shows:
- Methylphenidate reaches peak efficacy at approximately 45 mg/day (immediate-release equivalent)
- Lisdexamfetamine demonstrates peak efficacy at approximately 55 mg/day
- Both medications show similar effect sizes at their optimal doses (methylphenidate SMD -0.89; lisdexamfetamine SMD -1.05)
Ritalin LA 30mg considerations:
- Ritalin LA is an extended-release formulation that delivers methylphenidate in a biphasic pattern 2
- The 30mg dose of Ritalin LA approximates two 15mg immediate-release doses given 4 hours apart
- This represents a moderate therapeutic dose in the methylphenidate range
Practical Conversion Approach
Starting with Vyvanse 50mg is the most defensible initial equivalent because:
- FDA dosing guidance 3 recommends starting Vyvanse at 30mg and titrating in 10-20mg increments to a target of 50-70mg for ADHD
- The 50-70mg range represents the therapeutic sweet spot where lisdexamfetamine demonstrates maximal efficacy 1
- Ritalin LA 30mg sits in the middle therapeutic range for methylphenidate, suggesting a mid-range amphetamine dose is appropriate
Clinical Implementation Algorithm
When switching from Ritalin LA 30mg to Vyvanse:
- Start at Vyvanse 50mg once daily in the morning 3
- Assess response after 1 week
- If inadequate response: increase to 60mg, then 70mg at weekly intervals
- If excessive side effects: decrease to 40mg or 30mg
- Maximum dose: 70mg daily 3
Monitor specifically for:
- Appetite suppression and weight loss (more common with amphetamines)
- Sleep disturbances (dose in morning only) 3
- Cardiovascular effects (blood pressure, heart rate)
- Duration of symptom control (lisdexamfetamine typically provides 12-13 hours of coverage) 4
Important Caveats
There is no validated 1:1 conversion ratio between these medications because:
- They have different mechanisms (methylphenidate blocks reuptake; amphetamines also increase release) 3
- Individual patient response varies significantly
- Lisdexamfetamine is a prodrug requiring enzymatic conversion to active dextroamphetamine 3
The switch requires careful titration rather than direct substitution. Guidelines emphasize that medication adjustments are "the rule and not the exception" in ADHD treatment 5.
If the patient had inadequate response to methylphenidate, lisdexamfetamine is specifically recommended as the preferred next option over non-stimulants 5, supporting this switch.
Renal function matters: If the patient has severe renal impairment, maximum Vyvanse dose should not exceed 50mg; in end-stage renal disease, maximum is 30mg 3.